Europe Human Insulin Market Size, Share & COVID-19 Impact Analysis, By Type (Analog Insulin, and Traditional Insulin), By Diabetes Type (Diabetes 1, and Diabetes 2), By Distribution Channel (Hospital Pharmacy, and Retail & Online Pharmacy), and Regional Forecast, 2023-2030

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI107467

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Pipeline Analysis, By Key Players
2. Pricing Analysis, By Key Countries, 2022
3. Prevalence of Diabetes, By Key Countries, 2022
4. Brand Analysis – By Key Countries
5. Key Market Strategies, By Key Players
6. Overview of Regulatory Scenario – For Key Countries/Sub-regions
7. Impact of COVID-19 on the Market
Europe Human Insulin Market Analysis, Insights and Forecast, 2019-2030
1. Market Analysis, Insights and Forecast – By Type
  1. Analogue Insulin
    1. Long-acting
    2. Fast-acting
    3. Premix
  2. Traditional Human Insulin
    1. Long-acting
    2. Short-acting
    3. Fast-acting
    4. Premix
2. Market Analysis, Insights and Forecast – By Diabetes Type
  1. Diabetes Type 1
  2. Diabetes Type 2
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Retail & Online Pharmacies
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
    1. By Diabetes Type
  2. Germany
    1. By Diabetes Type
  3. France
    1. By Diabetes Type
  4. Italy
    1. By Diabetes Type
  5. Spain
    1. By Diabetes Type
  6. Scandinavia
    1. By Diabetes Type
  7. Rest of Europe
    1. By Diabetes Type
Competitive Analysis
1. Europe Market Share Analysis (2022)
2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
  1. Novo Nordisk A/S
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  2. Eli Lilly and Company
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  3. Sanofi
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  4. B. Braun Melsungen AG
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  5. WOCKHARDT
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  6. ADOCIA
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  7. Biocon
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  8. BIOTON S.A.
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  9. Lupin
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)
  10. Other Prominent Players
    1. Overview,
    2. Product,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. financials (Based on Availability)

Read Less

List of Figures

Figure 1: Europe Human Insulin Market Value (USD billion), by Type, 2022 & 2030

Figure 2: Europe Human Insulin Market Value Share (%), by Type, 2022

Figure 3: Europe Human Insulin Market Value (USD billion), by Diabetes Type, 2022 & 2030

Figure 4: Europe Human Insulin Market Value Share (%), by Diabetes Type, 2022

Figure 5: Europe Human Insulin Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 6: Europe Human Insulin Market Value Share (%), by Distribution Channel, 2022

Figure 7: Europe Human Insulin Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 8: Europe Human Insulin Market Value Share (%), By Country/ Sub-region, 2022

Figure 9: Europe Human Insulin Market Share (%), By Company, 2022

List of Tables

Table 1: Europe Human Insulin Market Revenue (USD billion) Forecast, by Type, 2019-2030

Table 2: Europe Human Insulin Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2030

Table 3: Europe Human Insulin Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 4: Europe Human Insulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 5: U.K. Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2030

Table 6: Germany Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2030

Table 7: France Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2030

Table 8: Italy Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2030

Table 9: Spain Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2030

Table 10: Scandinavia Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2030

Table 11: Rest of Europe Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2030

STUDY PERIOD: 2019-2030
BASE YEAR:2022
HISTORICAL DATA: 2019-2021
NO OF PAGES: 109

Consulting Services

Healthcare Clients

Related Reports

Get in Touch with Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
[email protected]